Literature DB >> 32169969

Deletion of Voltage-Gated Calcium Channels in Astrocytes during Demyelination Reduces Brain Inflammation and Promotes Myelin Regeneration in Mice.

Norma N Zamora1, Veronica T Cheli1, Diara A Santiago González1, Rensheng Wan1, Pablo M Paez2.   

Abstract

To determine whether Cav1.2 voltage-gated Ca2+ channels contribute to astrocyte activation, we generated an inducible conditional knock-out mouse in which the Cav1.2 α subunit was deleted in GFAP-positive astrocytes. This astrocytic Cav1.2 knock-out mouse was tested in the cuprizone model of myelin injury and repair which causes astrocyte and microglia activation in the absence of a lymphocytic response. Deletion of Cav1.2 channels in GFAP-positive astrocytes during cuprizone-induced demyelination leads to a significant reduction in the degree of astrocyte and microglia activation and proliferation in mice of either sex. Concomitantly, the production of proinflammatory factors such as TNFα, IL1β and TGFβ1 was significantly decreased in the corpus callosum and cortex of Cav1.2 knock-out mice through demyelination. Furthermore, this mild inflammatory environment promotes oligodendrocyte progenitor cells maturation and myelin regeneration across the remyelination phase of the cuprizone model. Similar results were found in animals treated with nimodipine, a Cav1.2 Ca2+ channel inhibitor with high affinity to the CNS. Mice of either sex injected with nimodipine during the demyelination stage of the cuprizone treatment displayed a reduced number of reactive astrocytes and showed a faster and more efficient brain remyelination. Together, these results indicate that Cav1.2 Ca2+ channels play a crucial role in the induction and proliferation of reactive astrocytes during demyelination; and that attenuation of astrocytic voltage-gated Ca2+ influx may be an effective therapy to reduce brain inflammation and promote myelin recovery in demyelinating diseases.SIGNIFICANCE STATEMENT Reducing voltage-gated Ca2+ influx in astrocytes during brain demyelination significantly attenuates brain inflammation and astrocyte reactivity. Furthermore, these changes promote myelin restoration and oligodendrocyte maturation throughout remyelination.
Copyright © 2020 the authors.

Entities:  

Keywords:  Cav1.2; astrocytes; myelination; oligodendrocytes; remyelination; voltage-gated Ca2+ channels

Year:  2020        PMID: 32169969      PMCID: PMC7178909          DOI: 10.1523/JNEUROSCI.1644-19.2020

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  57 in total

1.  Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway.

Authors:  R E Dolmetsch; U Pajvani; K Fife; J M Spotts; M E Greenberg
Journal:  Science       Date:  2001-10-12       Impact factor: 47.728

2.  L-type voltage-sensitive calcium channels mediate synaptic activation of immediate early genes.

Authors:  T H Murphy; P F Worley; J M Baraban
Journal:  Neuron       Date:  1991-10       Impact factor: 17.173

3.  Nimodipine protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation.

Authors:  Yachen Li; Xiaoming Hu; Yuxin Liu; Yongming Bao; Lijia An
Journal:  Neuropharmacology       Date:  2008-11-21       Impact factor: 5.250

4.  Upregulation of L-type Ca2+ channels in reactive astrocytes after brain injury, hypomyelination, and ischemia.

Authors:  R E Westenbroek; S B Bausch; R C Lin; J E Franck; J L Noebels; W A Catterall
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

5.  Role of ion flux in the control of c-fos expression.

Authors:  J I Morgan; T Curran
Journal:  Nature       Date:  1986 Aug 7-13       Impact factor: 49.962

6.  Anti-stress effects of cilnidipine and nimodipine in immobilization subjected mice.

Authors:  Naresh Kumar; Nirmal Singh; Amteshwar Singh Jaggi
Journal:  Physiol Behav       Date:  2011-12-22

7.  Neuronal activity-dependent cell survival mediated by transcription factor MEF2.

Authors:  Z Mao; A Bonni; F Xia; M Nadal-Vicens; M E Greenberg
Journal:  Science       Date:  1999-10-22       Impact factor: 47.728

Review 8.  Extracellular cues influencing oligodendrocyte differentiation and (re)myelination.

Authors:  Natalie A Wheeler; Babette Fuss
Journal:  Exp Neurol       Date:  2016-03-23       Impact factor: 5.330

Review 9.  Pharmacological basis for the use of nimodipine in central nervous system disorders.

Authors:  A Scriabine; T Schuurman; J Traber
Journal:  FASEB J       Date:  1989-05       Impact factor: 5.191

10.  A robust and high-throughput Cre reporting and characterization system for the whole mouse brain.

Authors:  Linda Madisen; Theresa A Zwingman; Susan M Sunkin; Seung Wook Oh; Hatim A Zariwala; Hong Gu; Lydia L Ng; Richard D Palmiter; Michael J Hawrylycz; Allan R Jones; Ed S Lein; Hongkui Zeng
Journal:  Nat Neurosci       Date:  2009-12-20       Impact factor: 24.884

View more
  15 in total

1.  Siponimod ameliorates metabolic oligodendrocyte injury via the sphingosine-1 phosphate receptor 5.

Authors:  Newshan Behrangi; Leo Heinig; Linda Frintrop; Emily Santrau; Jens Kurth; Bernd Krause; Dimitrinka Atanasova; Tim Clarner; Athanassios Fragoulis; Markus Joksch; Henrik Rudolf; Sven G Meuth; Sarah Joost; Markus Kipp
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-26       Impact factor: 12.779

2.  Lanthionine Ketimine Ethyl Ester Accelerates Remyelination in a Mouse Model of Multiple Sclerosis.

Authors:  Jeffrey L Dupree; Pablo M Paez; Seema K Tiwari-Woodruff; Travis T Denton; Kenneth Hensley; Christina G Angeliu; Anne I Boullerne; Sergey Kalinin; Sophia Egge; Veronica T Cheli; Giancarlo Denaroso; Kelley C Atkinson; Micah Feri; Douglas L Feinstein
Journal:  ASN Neuro       Date:  2022 Jan-Dec       Impact factor: 5.200

3.  Inhibition of Transient Receptor Potential Vanilloid 4 (TRPV4) Mitigates Seizures.

Authors:  Meng-Liu Zeng; Jing-Jing Cheng; Shuo Kong; Xing-Liang Yang; Xiang-Lei Jia; Xue-Lei Cheng; Ling Chen; Fang-Gang He; Yu-Min Liu; Yuan-Teng Fan; Lanzi Gongga; Tao-Xiang Chen; Wan-Hong Liu; Xiao-Hua He; Bi-Wen Peng
Journal:  Neurotherapeutics       Date:  2022-02-18       Impact factor: 6.088

4.  CaMKII and CaV3.2 T-type calcium channel mediate Connexin-43-dependent inflammation by activating astrocytes in vincristine-induced neuropathic pain.

Authors:  Gui-Zhou Li; Ya-Hui Hu; Yi-Ni Lu; Qing-Yan Yang; Di Fu; Feng Chen; Yun-Man Li
Journal:  Cell Biol Toxicol       Date:  2021-07-20       Impact factor: 6.691

5.  Design of an Imaging Probe to Monitor Real-Time Redistribution of L-type Voltage-Gated Calcium Channels in Astrocytic Glutamate Signaling.

Authors:  Mitra Sadat Tabatabaee; Jeff Kerkovius; Frederic Menard
Journal:  Mol Imaging Biol       Date:  2021-01-12       Impact factor: 3.488

Review 6.  Canavan Disease as a Model for Gene Therapy-Mediated Myelin Repair.

Authors:  Anoushka Lotun; Dominic J Gessler; Guangping Gao
Journal:  Front Cell Neurosci       Date:  2021-04-23       Impact factor: 6.147

7.  Nimodipine Exerts Beneficial Effects on the Rat Oligodendrocyte Cell Line OLN-93.

Authors:  Felix Boltz; Michael Enders; Andreas Feigenspan; Philipp Kirchner; Arif Ekici; Stefanie Kuerten
Journal:  Brain Sci       Date:  2022-04-04

Review 8.  Altered Expression of Ion Channels in White Matter Lesions of Progressive Multiple Sclerosis: What Do We Know About Their Function?

Authors:  Francesca Boscia; Maria Louise Elkjaer; Zsolt Illes; Maria Kukley
Journal:  Front Cell Neurosci       Date:  2021-06-25       Impact factor: 5.505

Review 9.  Astrocytic Calcium Dynamics Along the Pain Pathway.

Authors:  Jeiwon Cho; Yeowool Huh
Journal:  Front Cell Neurosci       Date:  2020-10-16       Impact factor: 5.505

10.  Astrocytic YAP protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model through TGF-β signaling.

Authors:  Qian Wu; Xuemeng Miao; Jingjing Zhang; Ludan Xiang; Xiuchun Li; Xiaomei Bao; Siyu Du; Mianxian Wang; Shuangda Miao; Yiren Fan; Wei Wang; Xingxing Xu; Xiya Shen; Danlu Yang; Xiwu Wang; Yuanyuan Fang; Lixin Hu; Xuyi Pan; Haoru Dong; Hui Wang; Ying Wang; Jia Li; Zhihui Huang
Journal:  Theranostics       Date:  2021-07-25       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.